Skip to content
MLCI

Mount Logan Capital Inc. Common Stock

Mount Logan Capital Inc. Common Stock Q4 FY2025 earnings call

March 19, 2026 · fiscal period ended 2025-12

EPS · actual vs est

$-4.15 / $-0.01Miss -41400.0%

Revenue · actual vs est

$-1.2M / $13.2MMiss -109.4%
Ask about this call

Summary

Generated 2026-03-19

Management highlights

• 2025 was transformational with business combination, re-domiciliation to US, listing on NASDAQ. • Focused on scaling BDC ecosystem, including investments in Runway Growth Capital and mergers of BDCs. • Made significant investments in Ability Insurance Company to expand insurance capabilities. • Announced Yieldstreet transaction expected to drive AUM growth and increase FRE. • Completed bond offering, tender offer, and signed expanded managed account agreement.

View in transcript ↓

Segment performance

Asset Management Segment: Fourth quarter 2025 revenue, including investment income, was $2.6 million vs $3.8 million prior year; full year revenue, including investment income, was $21.5 million, up 44% y-o-y. Management fees down 14% y-o-y, incentive fees down 50% y-o-y. Insurance Solutions: Fourth quarter 2025 net investment income was $14.8 million, down 21% from prior year; full year net investment income was $79 million, down 15% y-o-y. Recognized $25 million goodwill impairment related to legacy long-term care block.

View in transcript ↓

Guidance

• Expect FRE and SRE to improve in 2026. • The Yieldstreet deal is expected to lead to material FRE growth, with impact seen in second half of 2026. • Expect to be active on M&A front with inorganic growth opportunities. • Plan to see SRE benefit from insurance side in second half of 2026.

View in transcript ↓

Q&A highlights

Q: FRE numbers have been lower, when will growth resume?

A: Expect growth this year with Vista Life mandate and Yieldstreet deal.

Q: How does Yieldstreet deal impact FRE?

A: Leads to nice bump in FRE on run rate basis, impact seen in second half of 2026.

Q: Thoughts on macro and competitive environment?

A: Portfolio in good shape, private lending still competitive.

Q: How much does Yieldstreet deal impact FRE?

A: Immediate 30% accretion to FRE on run rate basis.

Q: Capital contributed to Ability?

A: Injected capital from 180 degree deal, expect SRE benefit in second half of 2026.

Q: Credit quality and AI risk?

A: Diversified portfolios, underweight software, haven't seen weakness in portfolio yet.

Q: Timeline for insurance direct writing?

A: Expect to get rating in next four or six weeks, start direct writing in third quarter.

Q: Dividend policy?

A: Prioritize growing FRE vs returning capital, reassess dividend as FRE scales

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$-4.15$-0.01-41400.0%
Revenue$-1.2M$13.2M-109.4%

Transcript

March 19, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.